Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: May 2, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| JD | JDCOM INC | A | C | $47.80B | 2,909,925,451 | 10.09% | 0.00% | ||
| RL | RALPH LAUREN CORP | A | C | $13.87B | 61,764,215 | 64.56% | 3.54% | Net Selling | Net Selling |
| WIX | WIXCOM LTD | A | B | $9.42B | 56,107,932 | 85.07% | 0.00% | ||
| KBR | KBR INC | A | C | $6.96B | 132,441,673 | 45.11% | 54.89% | Net Selling | Net Selling |
| BGC | BGC GROUP INC | A | B | $4.36B | 482,883,531 | 37.40% | 62.60% | Net Selling | Net Selling |
| INGM | INGRAM MICRO HOLDING CORP | A | C | $4.22B | 234,825,581 | 52.37% | 47.63% | Net Selling | |
| SGHC | SUPER GROUP (SGHC) LTD | A | B | $4.10B | 503,407,783 | 7.98% | 0.00% | ||
| KMPR | KEMPER CORP | A | B | $3.78B | 63,900,557 | 63.82% | 36.18% | Net Selling | Net Selling |
| PRIM | PRIMORIS SERVICES CORP | A | B | $3.43B | 53,747,628 | 77.08% | 22.92% | Net Selling | Net Selling |
| CPRX | CATALYST PHARMACEUTICALS INC | A | A | $2.95B | 121,449,655 | 80.39% | 16.12% | Net Buying | Net Selling |
| AMRX | AMNEAL PHARMACEUTICALS INC | A | C | $2.40B | 309,966,341 | 25.22% | 74.78% | Net Selling | Net Selling |
| TTMI | TTM TECHNOLOGIES INC | A | A | $2.38B | 102,108,642 | 69.94% | 30.06% | Net Selling | Net Selling |
| FINV | FINVOLUTION GROUP | A | C | $2.02B | 1,266,250,724 | 5.69% | 0.00% | ||
| LIVN | LIVANOVA PLC | A | C | $2.00B | 54,351,765 | 90.78% | 9.22% | Net Selling | Net Selling |
| ARDT | ARDENT HEALTH PARTNERS INC | A | A | $1.80B | 142,750,013 | 48.19% | 51.81% | Net Selling | Net Selling |
| ADEA | ADEIA INC | A | B | $1.33B | 107,508,991 | 91.89% | 8.11% | Net Selling | Net Selling |
| TASK | TASKUS INC | A | C | $1.26B | 89,996,796 | 17.93% | 2.62% | Net Selling | Net Selling |
| AHCO | ADAPTHEALTH CORP | A | B | $1.15B | 134,867,011 | 49.11% | 50.89% | Net Selling | |
| EVER | EVERQUOTE INC | A | A | $936.68M | 35,723,964 | 55.58% | 44.42% | Net Selling | Net Selling |
| YEXT | YEXT INC | A | C | $838.59M | 126,484,781 | 55.01% | 44.99% | Net Selling | Net Selling |
| CINT | CI&T INC | A | C | $781.16M | 134,682,256 | 44.48% | 0.00% | ||
| HCKT | HACKETT GROUP INC | A | A | $713.12M | 27,791,221 | 46.88% | 53.12% | Net Selling | Net Selling |
| NEXN | NEXXEN INTERNATIONAL LTD | A | C | $330.11M | 65,562,670 | 5.82% | 0.00% | ||
| PMTS | CPI CARD GROUP INC | A | A | $292.93M | 11,240,507 | 31.25% | 68.75% | Net Selling | Net Selling |
| EXFY | EXPENSIFY INC | A | C | $268.75M | 91,412,535 | 32.74% | 14.89% | Net Selling | Net Selling |
| QUAD | QUAD/GRAPHICS INC | A | B | $242.94M | 50,612,503 | 40.88% | 19.75% | Net Selling | Net Selling |
| UEIC | UNIVERSAL ELECTRONICS INC | A | A | $57.30M | 13,111,653 | 57.45% | 42.55% | Net Selling | Net Selling |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have a premium account? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.